Rethinking Substance Abuse

What the Science Shows, and What We Should Do about It

Edited by William R. Miller and Kathleen M. Carroll

HardcoverPaperbacke-bookprint + e-book
Hardcover
February 15, 2006
ISBN 9781572302310
Price: $92.00
320 Pages
Size: 6" x 9"
order
Paperback
June 3, 2010
ISBN 9781606236987
Price: $42.00
320 Pages
Size: 6" x 9"
order
e-book
September 26, 2012
PDF and ePub ?
Price: $42.00
320 Pages
order
print + e-book
Paperback + e-Book (PDF and ePub) ?
Price: $84.00 $50.40
320 Pages
order
bookProfessors: request an exam copy

Read a Q&A with featured author, William R. Miller!
Sign up for emails on upcoming titles on Addictions (with special discounts)!
Warren K. Bickel, PhD, Department of Psychiatry and Center for Addiction Research, University of Arkansas for Medical Sciences, Little Rock, Arizona

Robert G. Carlson, PhD, Center for Interventions, Treatment, and Addictions Research, Department of Community Health, Wright State University Boonshoft School of Medicine, Dayton, Ohio

Kathleen M. Carroll, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut; Department of Psychiatry, Veterans Affairs Connecticut Healthcare Center, West Haven, Connecticut

Anna Rose Childress, PhD, Addiction Treatment Research Center and Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

Carlo C. DiClemente, PhD, Department of Psychology, University of Maryland, Baltimore, Maryland

Robert E. Drake, MD, Departments of Psychiatry and Community and Family Medicine, New Hampshire-Dartmouth Psychiatric Research Center, Dartmouth Medical School, Hanover, New Hampshire

Elizabeth Gifford, PhD, Program Evaluation and Resource Center, Veterans Affairs Health Care System, Menlo Park, California

Deborah Hasin, PhD, Departments of Epidemiology and Psychiatry, Columbia University, New York, New York; Department of Research Assessment and Training, New York State Psychiatric Institute, New York, New York

Mark Hatzenbuehler, BA, Department of Psychology, Yale University, New Haven, Connecticut

Michie N. Hesselbrock, PhD, University of Connecticut School of Social Work, West Hartford, Connecticut

Victor M. Hesselbrock, PhD, Department of Psychiatry, University of Connecticut Health Center, Farmington, Connecticut

Harold D. Holder, PhD, Prevention Research Center, Pacific Institute for Research and Evaluation, Berkeley, California

Keith Humphreys, MD, Program Evaluation and Resource Center, Veterans Affairs Health Care System, Menlo Park, California

George F. Koob, PhD, Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California

Thomas R. Kosten, MD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut; Department of Psychiatry, Veterans Affairs Connecticut Healthcare Center, West Haven, Connecticut

Barbara S. McCrady, PhD, Graduate School of Applied and Professional Psychology and Center of Alcohol Studies, Rutgers University, Piscataway, New Jersey

Mark McGovern, PhD, Department of Psychiatry, New Hampshire-Dartmouth Psychiatric Research Center, Dartmouth Medical School, Hanover, New Hampshire

A. Thomas McLellan, PhD, Treatment Research Institute, Philadelphia, Pennsylvania

William R. Miller, PhD, Departments of Psychology and Psychiatry, University of New Mexico, Albuquerque, New Mexico

Rudolf H. Moos, PhD, Center for Health Care Evaluation, Veterans Affairs Health Care System, Menlo Park, California; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California

Kim T. Mueser, PhD, Departments of Psychiatry and Community and Family Medicine, New Hampshire-Dartmouth Psychiatric Research Center, Dartmouth Medical School, Hanover, New Hampshire

Stephanie S. O'Malley, PhD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut

Marc N. Potenza, MD, Problem Gambling Clinic, Connecticut Mental Health Center, New Haven, Connecticut; Women and Addictions Core of Women's Health Research and Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut

Bruce J. Rounsaville, MD, Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut; Department of Psychiatry, Veterans Affairs Connecticut Healthcare Center, West Haven, Connecticut

Win Turner, PhD, Department of Psychiatry, Dartmouth Medical School, Hanover, New Hampshire

Rachel Waxman, BA, Department of Research Assessment and Training, New York State Psychiatric Institute, New York, New York